Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 5,440.00
-70.00 (-1.27%)
Jul 21, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 30.47 billion as of July 21, 2026. Its market cap has decreased by -50.63% in one year.
Market Cap
30.47B
Enterprise Value
16.08B
Revenue
30.41B
Ranking
n/a
PE Ratio
5.76
Stock Price
5,440.00
ChartMarket Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 30.47B, a decrease of -89.40%. That is a compound annual growth rate of -69.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 30.47B | -44.06% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.26T |
| Celltrion | 39.58T |
| ALTEOGEN | 14.44T |
| Samsung Epis Holdings | 9.27T |
| Oncocross | 37.81B |
| Gencurix | 35.28B |
| HASS Corp. | 34.96B |
| BCWORLD PHARM. | 32.08B |